16 June 2024 - Two new Alzheimer’s drugs aimed at slowing cognitive delay and heralded as a step towards prevention are expected to be given the green light for Australian patients soon.
They are the first drugs to get approval internationally for treatment of the life-limiting illness in more than 20 years, but local experts are warning that the medications are expensive, need monitoring and may be available to only about 15% of those living with Alzheimer’s disease.